564 related articles for article (PubMed ID: 33720327)
1. Therapeutic Drug Monitoring of Second- and Third-Generation Antiepileptic Drugs.
Krasowski MD; Long TA; Snozek CLH; Dizon A; Magnani B; Melanson SEF
Arch Pathol Lab Med; 2021 Dec; 145(12):1485-1491. PubMed ID: 33720327
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine.
Martinez Ferri M; Peña Mayor P; Perez López-Fraile I; Escartin Siquier A; Martin Moro M; Forcadas Berdusan M;
Neurologia (Engl Ed); 2018 Mar; 33(2):78-84. PubMed ID: 27452623
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
Johannessen SI; Tomson T
Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
[TBL] [Abstract][Full Text] [Related]
5. Antiepileptic Drug Treatment in Community-Dwelling Older Patients with Epilepsy: A Retrospective Observational Study of Old- Versus New-Generation Antiepileptic Drugs.
Theitler J; Brik A; Shaniv D; Berkovitch M; Gandelman-Marton R
Drugs Aging; 2017 Jun; 34(6):479-487. PubMed ID: 28478592
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy.
Otoul C; Arrigo C; van Rijckevorsel K; French JA
Clin Neuropharmacol; 2005; 28(2):72-8. PubMed ID: 15795549
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic Drugs.
Abou-Khalil BW
Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):132-56. PubMed ID: 26844734
[TBL] [Abstract][Full Text] [Related]
8. New antiepileptic drugs: review on drug interactions.
Hachad H; Ragueneau-Majlessi I; Levy RH
Ther Drug Monit; 2002 Feb; 24(1):91-103. PubMed ID: 11805729
[TBL] [Abstract][Full Text] [Related]
9. [Antiepileptic drugs in North America].
Akiyama T; Otsubo H
Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099
[TBL] [Abstract][Full Text] [Related]
10. Some common issues in the use of antiepileptic drugs.
Asconapé JJ
Semin Neurol; 2002 Mar; 22(1):27-39. PubMed ID: 12170391
[TBL] [Abstract][Full Text] [Related]
11. Current state of the union of epilepsy care in the United States: Antiepileptic drugs - An introduction to the Connectors Project.
Sirven JI; Shafer PO; Kalilani L; Wild I; Fishman J; Owens S
Epilepsy Behav; 2018 Mar; 80():98-103. PubMed ID: 29414565
[TBL] [Abstract][Full Text] [Related]
12. Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain.
Guay DR
Am J Geriatr Pharmacother; 2003 Sep; 1(1):18-37. PubMed ID: 15555463
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
Contin M; Albani F; Riva R; Baruzzi A
Ther Drug Monit; 2004 Aug; 26(4):375-9. PubMed ID: 15257066
[TBL] [Abstract][Full Text] [Related]
14. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
Contin M; Riva R; Albani F; Avoni P; Baruzzi A
Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
[TBL] [Abstract][Full Text] [Related]
15. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs.
Patsalos PN; Perucca E
Lancet Neurol; 2003 Jun; 2(6):347-56. PubMed ID: 12849151
[TBL] [Abstract][Full Text] [Related]
16. Drug interactions involving the new second- and third-generation antiepileptic drugs.
Johannessen Landmark C; Patsalos PN
Expert Rev Neurother; 2010 Jan; 10(1):119-40. PubMed ID: 20021326
[TBL] [Abstract][Full Text] [Related]
17. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Drug Monitoring of Newer Antiepileptic Drugs: A Randomized Trial for Dosage Adjustment.
Aícua-Rapún I; André P; Rossetti AO; Ryvlin P; Hottinger AF; Decosterd LA; Buclin T; Novy J
Ann Neurol; 2020 Jan; 87(1):22-29. PubMed ID: 31714640
[TBL] [Abstract][Full Text] [Related]
19. An audit of lamotrigine, levetiracetam and topiramate usage for epilepsy in a district general hospital.
Chappell B; Crawford P
Seizure; 2005 Sep; 14(6):422-8. PubMed ID: 16087359
[TBL] [Abstract][Full Text] [Related]
20. Genotoxicity assessment of antiepileptic drugs (AEDs) in human embryonic stem cells.
Kardoost M; Hajizadeh-Saffar E; Ghorbanian MT; Ghezelayagh Z; Pooshang Bagheri K; Behdani M; Habibi-Anbouhi M
Epilepsy Res; 2019 Dec; 158():106232. PubMed ID: 31707315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
